Bank of New York Mellon’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-68,277
| Closed | -$9.33M | – | 4303 |
|
|
2018
Q2 | $9.33M | Buy |
68,277
+1,120
| +2% | +$102K | ﹤0.01% | 2055 |
|
|
2018
Q1 | $5.29M | Buy |
67,157
+499
| +0.7% | +$36.8K | ﹤0.01% | 2324 |
|
|
2017
Q4 | $4.55M | Buy |
66,658
+1,081
| +2% | +$56.1K | ﹤0.01% | 2402 |
|
|
2017
Q3 | $2.64M | Buy |
65,577
+3,980
| +6% | +$154K | ﹤0.01% | 2676 |
|
|
2017
Q2 | $2.45M | Buy |
61,597
+835
| +1% | +$30.6K | ﹤0.01% | 2730 |
|
|
2017
Q1 | $1.96M | Buy |
60,762
+2,232
| +4% | +$55.7K | ﹤0.01% | 2862 |
|
|
2016
Q4 | $1.04M | Buy |
58,530
+2,053
| +4% | +$44.2K | ﹤0.01% | 3245 |
|
|
2016
Q3 | $1.32M | Sell |
56,477
-3,045
| -5% | -$69.1K | ﹤0.01% | 3025 |
|
|
2016
Q2 | $1.11M | Buy |
59,522
+74
| +0.1% | +$1.34K | ﹤0.01% | 3068 |
|
|
2016
Q1 | $1.08M | Sell |
59,448
-457
| -0.8% | -$7.36K | ﹤0.01% | 3006 |
|
|
2015
Q4 | $1.26M | Buy |
59,905
+5,058
| +9% | +$97.5K | ﹤0.01% | 3017 |
|
|
2015
Q3 | $1.01M | Sell |
54,847
-13,130
| -19% | -$328K | ﹤0.01% | 3179 |
|
|
2015
Q2 | $2.3M | Sell |
67,977
-12,782
| -16% | -$514K | ﹤0.01% | 2817 |
|
|
2015
Q1 | $3.88M | Buy |
80,759
+7,939
| +11% | +$360K | ﹤0.01% | 2457 |
|
|
2014
Q4 | $1.62M | Buy |
72,820
+1,384
| +2% | +$31.9K | ﹤0.01% | 3003 |
|
|
2014
Q3 | $1.35M | Buy |
71,436
+19,148
| +37% | +$457K | ﹤0.01% | 3120 |
|
|
2014
Q2 | $1.41M | Buy |
52,288
+7,360
| +16% | +$187K | ﹤0.01% | 3115 |
|
|
2014
Q1 | $1.45M | Sell |
44,928
-5,945
| -12% | -$193K | ﹤0.01% | 3092 |
|
|
2013
Q4 | $1.21M | Buy |
+50,873
| New | +$1.42M | ﹤0.01% | 3197 |
|
Bank of New York Mellon's FMI Position: Q3 2018 in Review
Bank of New York Mellon sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 68,277 shares — an estimated $9.33M sold.
Bank of New York Mellon first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $9.33M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Bank of New York Mellon reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Bank of New York Mellon sold 68,277 Foundation Medicine, Inc. shares in Q3 2018, an estimated $9.33M.
- Bank of New York Mellon first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
- Bank of New York Mellon's Foundation Medicine, Inc. position peaked at $9.33M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Bank of New York Mellon's 13F filing for Q3 2018, filed 9 Nov 2018.